Array BioPharma, Inc. To Present At The Jefferies and Co. 2015 Global Healthcare Conference

BOULDER, Colo., May 26, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Jefferies 2015 Global Healthcare Conference in New York City. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   

Event:




Jefferies 2015 Global Healthcare Conference

Presenter:




Ron Squarer, Chief Executive Officer

Date:




Tuesday, June 2, 2015

Time:




1:30 p.m. Eastern Time

Webcast:




www.arraybiopharma.com

 

Array BioPharma.

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six Phase 3 studies are currently advancing. These programs include three cancer drugs, binimetinib (MEK162 / wholly-owned), encorafenib (LGX818 / wholly-owned) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.

CONTACT:

Tricia Haugeto


Array BioPharma Inc.


303-386-1193


thaugeto@arraybiopharma.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-jefferies-2015-global-healthcare-conference-300087967.html

SOURCE Array BioPharma Inc.

Help employers find you! Check out all the jobs and post your resume.

Back to news